RBC Capital Markets initiated coverage on IQVIA Holdings Inc. (NYSE:IQV), noting the company's biggest differentiator is its data assets. The analyst says IQVIA is the largest global contract research organization.
The analyst notes investor sentiment and EPS growth have been significantly impacted over the past 2.5 years due to persistent challenges from the COVID-19 pandemic, rising interest expenses, a declining biopharma funding environment, and weaker discretionary and commercial demand.
Also Read: IQVIA ‘Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings.
As a result, the stock has underperformed the S&P 500 by about 26% since Q1 2022.
RBC writes that IQVIA offers the best exposure to the vast AI and data opportunities in ...
